Zhejiang Benli Technology Co.Ltd(301065) 425 issued the annual report for 2021. The company's overall operation was stable throughout the year, with an operating revenue of 6211046 million yuan, a decrease of 0.60% over the same period of the previous year; The net profit attributable to the listed company was 548249 million yuan, a decrease of 40.22% over the same period last year. The annual equity distribution plan of the company in 2021 is to distribute a cash dividend of 3.50 yuan to all shareholders for every 10 shares, with a total cash dividend of 24.738 million yuan, accounting for 45.12% of the net profit attributable to the parent company in the same period.
Zhejiang Benli Technology Co.Ltd(301065) has been rooted in the field of chemical intermediates for more than ten years. After years of research and development, it has formed a series of patented and non patented technologies with carbon monoxide carbonylation reaction technology, carbon tetrachloride Foucault reaction technology and green synthesis technology of quinolone API as the core. Now it has 20 invention patents, 6 utility models and 6 software copyrights.
During the reporting period, the company has received the reply of Taizhou Ecological Environment Bureau on the environmental impact report of Zhejiang Benli Technology Co.Ltd(301065) annual output of 2000 tons of uracil, 1400 tons of norfloxacin API and pharmaceutical intermediate technical transformation project.
As the first research enterprise in the green synthesis of quinolone API and the new process of key intermediates, Zhejiang Benli Technology Co.Ltd(301065) has the first mover advantage in the market Zhejiang Benli Technology Co.Ltd(301065) the upstream industrial chain of main products is basic chemical raw materials, and the downstream industrial chain is medicine, pesticide, new materials and other application industries. During the reporting period, the price of upstream raw materials rose sharply, coupled with the cancellation of preferential policies such as social security fee reduction due to the epidemic, as well as the trial production of new production lines during the reporting period and low capacity utilization, resulting in a significant increase in the cost of main products and a decrease in the company's net profit compared with the same period last year.
In 2022, Zhejiang Benli Technology Co.Ltd(301065) will actively promote the construction of raised investment projects, further expand the company's production capacity, improve the application coverage of quinolone API, continue to expand the application fields of the company's products to pesticides, fungicides, pesticides and photoinitiators of new materials, further improve the production chain and reduce business risks.
